BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32715335)

  • 1. CT and MR imaging surveillance of stage 1 renal cell carcinoma after microwave ablation.
    Wetley KA; Abel EJ; Dreyfuss LD; Huang W; Brace CL; Wells SA
    Abdom Radiol (NY); 2020 Sep; 45(9):2810-2824. PubMed ID: 32715335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
    Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
    Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
    Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
    Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.
    Klapperich ME; Abel EJ; Ziemlewicz TJ; Best S; Lubner MG; Nakada SY; Hinshaw JL; Brace CL; Lee FT; Wells SA
    Radiology; 2017 Jul; 284(1):272-280. PubMed ID: 28076721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of iodinated contrast material on post-operative eGFR when administered during renal mass ablation.
    Curci NE; Triche BL; Abel EJ; Bhutani G; Maciolek KA; Dreyfuss LD; Allen GO; Caoili EM; Davenport MS; Wells SA
    Eur Radiol; 2021 Aug; 31(8):5490-5497. PubMed ID: 33492471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma.
    Aarts BM; Prevoo W; Meier MAJ; Bex A; Beets-Tan RGH; Klompenhouwer EG; Gómez FM
    Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1025-1033. PubMed ID: 32052093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?
    Yu J; Wang H; Cheng ZG; Liu FY; Li QY; He GZ; Luo YC; Yu XL; Han ZY; Liang P
    Eur Radiol; 2022 Jan; 32(1):89-100. PubMed ID: 34195888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of CT-guided microwave ablation for stage T1a renal cell carcinoma in patients with a solitary kidney.
    Meng H; Yang H; Jia H; Pan F; Dong X; Liu B; Li C
    Int J Hyperthermia; 2021; 38(1):691-695. PubMed ID: 33899668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microwave treatment of renal cell carcinoma adjacent to renal sinus.
    Gao Y; Liang P; Yu X; Yu J; Cheng Z; Han Z; Duan S; Huang H
    Eur J Radiol; 2016 Nov; 85(11):2083-2089. PubMed ID: 27776662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study.
    Ierardi AM; Carnevale A; Rossi UG; Renzulli M; Garanzini E; Golfieri R; Macchione N; Cittanti C; Giganti M; Carrafiello G
    Med Oncol; 2020 Mar; 37(4):27. PubMed ID: 32166412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous microwave ablation of renal cancers under CT guidance: safety and efficacy with a 2-year follow-up.
    Chan P; Vélasco S; Vesselle G; Boucebci S; Herpe G; Debaene B; Ingrand P; Irani J; Tasu JP
    Clin Radiol; 2017 Sep; 72(9):786-792. PubMed ID: 28545682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microwave ablation of cT1a renal cell carcinoma: oncologic and functional outcomes at a single center.
    Wilcox Vanden Berg RN; Calderon LP; LaRussa S; Enobakhare O; Craig K; Del Pizzo J; McClure TD
    Clin Imaging; 2021 Aug; 76():199-204. PubMed ID: 33964597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced CT immediately following percutaneous microwave ablation of cT1a renal cell carcinoma: Optimizing cancer outcomes.
    Koebe SD; Curci NE; Caoili EM; Triche BL; Dreyfuss LD; Allen GO; Brace CL; Davenport MS; Abel EJ; Wells SA
    Abdom Radiol (NY); 2022 Aug; 47(8):2674-2680. PubMed ID: 35278110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months.
    Merkle EM; Nour SG; Lewin JS
    Radiology; 2005 Jun; 235(3):1065-71. PubMed ID: 15914485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Study on the Efficacy of Microwave Ablation (MA) in the Treatment of Stage I Renal Clear Cell Carcinoma by CT and MRI Imaging.
    Zhu J; Chen S; Wang Y; Gao T; Ji Y; Wang S
    J Healthc Eng; 2022; 2022():8446294. PubMed ID: 35178237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma.
    Dreyfuss LD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Abel EJ
    Urology; 2019 Dec; 134():148-153. PubMed ID: 31465794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound.
    Chen CN; Liang P; Yu J; Yu XL; Cheng ZG; Han ZY; Liu FY; Li X
    Int J Hyperthermia; 2016 Sep; 32(6):607-13. PubMed ID: 27269816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
    Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
    World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous microwave ablation of T1a renal cell carcinomas: A 10-year single-center retrospective review.
    McCloskey C; Jacques A; McCloskey D; Tibballs J
    J Med Imaging Radiat Oncol; 2024 Apr; 68(3):297-302. PubMed ID: 38477383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.